Biotech · Private company · St. Louis, MO, US
Gateway Biotechnology, Inc.
Track this companyFree. Adds Gateway Biotechnology, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials30 recruiting or active
Pipeline programs1From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline1
- Distortion product otoacoustic emissions (DPOAE)Hearing LossClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- Noise-Induced Hearing Loss-Acute Exposure Treatment (UA)PHASE2 · TERMINATED · started Nov 10, 2021ClinicalTrials.gov NCT04774250 · fetched Nov 12, 2026
- Noise-Induced Hearing Loss-Acute Exposure TreatmentPHASE2 · TERMINATED · started Oct 4, 2021ClinicalTrials.gov NCT04768569 · fetched Nov 12, 2026
- Hearing Changes After SurgeryWITHDRAWN · started Sep 1, 2021ClinicalTrials.gov NCT04322747 · fetched Nov 12, 2026
NIH awards1
- Developing a clinical diagnostic tool for age-related cochlear synaptopathy.Fiscal year 2024 · $482.6KNIH RePORTER 5R42AG078721-03 · fetched Nov 12, 2026